Nanovibronix (NASDAQ:FEED) Issues Earnings Results

Nanovibronix (NASDAQ:FEED) announced its quarterly earnings results on Monday. The company reported ($6.88) earnings per share (EPS) for the quarter, FiscalAI reports. Nanovibronix had a negative net margin of 894.64% and a negative return on equity of 50.27%. The business had revenue of $0.65 million during the quarter.

Nanovibronix Stock Performance

FEED opened at $0.93 on Wednesday. The company’s fifty day moving average price is $1.60. The firm has a market cap of $3.44 million, a price-to-earnings ratio of -0.02 and a beta of 1.59. Nanovibronix has a twelve month low of $0.91 and a twelve month high of $17.40.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on FEED shares. Weiss Ratings reissued a “sell (e+)” rating on shares of Nanovibronix in a research report on Friday, April 24th. Wall Street Zen raised shares of Nanovibronix from a “strong sell” rating to a “sell” rating in a research report on Tuesday, April 28th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.

Nanovibronix Company Profile

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non?invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low?intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound?care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound?care clinics, long?term care facilities and patients requiring home?based therapies.